3-[(2s)-2-{[(4-methylphenyl)sulfonyl]amino}-3-oxo-3-piperidin-1-ylpropyl]benzenecarboximidamide (0ZG) Summary

Clusters summary
Clustering method gromos
Clustering metric RSMdi
Initial clustering cutoff (nm) 0.05
Final clustering cutoff (nm) 0.105
Number of clusters 33
Number of clusters representing 95% 9
Cluster Population
Clusters Convergence
ΔG WITH RESPECT TO BIOACTIVE CONFORMATION
ΔGdist (kcal/mol) 1.6278
ΔGstrain (kcal/mol) 0.9065
Conformations Table
ClNum ClPop ΔG Cl-Cl RMSd Exp
1 2958 0 3.4655
2 2178 0.1812 2.9062
3 1023 0.6287 2.3617
4 1015 0.6334 2.9914
5 742 0.8189 1.977
6 640 0.9065 1.944
7 450 1.1151 2.7666
8 324 1.3096 3.2354
9 275 1.4067 2.9585
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)
Negative probe (charge -1)
Neutral probe (charge 0)
Positive probe (charge +1)